When we focused on breast cancer, we first compared the differences of COL11A1 in independent samples or paired samples in online tumor databases, and then we collected clinicopathological specimens and cultured breast cancer cell lines by immunohistochemical staining and Western Blot experiments, respectively. This evidence concerns the gene COL11A1 and neoplasm.